BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ·Healthcare·Biotechnology
$7.58
-1.63%
Mkt Cap $2.16B
Analyst Ratings
Buy
7
Hold
1
Sell
0
Price Target (16 analysts)
$19.00
Range $11.00 – $29.00
Implied Upside
+150.7%
Consensus $19.00 vs current $7.58
NASDAQ·Healthcare·Biotechnology
$7.58
-1.63%
Mkt Cap $2.16B
Buy
7
Hold
1
Sell
0
Price Target (16 analysts)
$19.00
Range $11.00 – $29.00
+150.7%
Consensus $19.00 vs current $7.58